Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ankur Dhingra Insider Profile
11 Followers
Ankur Dhingra, CFO at CareDx, holds 8.83K shares in Illumina (Ticker: ILMN), holds 354.96K shares in Summit Therapeutics (Ticker: SMMT), holds 38.15K shares in CareDx (Ticker: CDNA).
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+122.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Ankur Dhingra holds in companies
Most Profitable Insider Trade
The most profitable trade made by Ankur Dhingra
Ankur Dhingra's Trading History
CareDx
Mar 28, 2022
CFO
Uninformative Sell
47.53K
$690.06K
Summit Therapeutics
Mar 27, 2024
CFO
Informative Buy
375.00K
$3.12M
Illumina
May 08, 2024
SVP, Chief Financial Officer
Uninformative Buy
―
$1.01M
List of latest transactions for each holding click on a transaction to see Ankur Dhingra's performance on stock
You May Also Like
Ankur Dhingra insider profile FAQ
What is the percentage of profitable transactions made by Ankur Dhingra?
The percentage of profitable transactions made by Ankur Dhingra is 80%.
What is the average return per transaction made by Ankur Dhingra?
The average return per transaction made by Ankur Dhingra is 122.20%.
What stocks does Ankur Dhingra hold?
Ankur Dhingra holds: CDNA, SMMT, ILMN stocks.
What was Ankur Dhingra’s latest transaction?
Ankur Dhingra latest transaction was an Uninformative Buy of ―.
What was Ankur Dhingra's most profitable transaction?
Ankur Dhingra’s most profitable transaction was an Informative Buy of SMMT stock on December 13, 2023. The return on the trade was 275.40%.
What is Ankur Dhingra's role in CareDx?
Ankur Dhingra's role in CareDx is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.